Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare Biotechnology

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc

Bullboard Posts

Comment by Stylesson Aug 27, 2013 7:47pm

486 Views

Post# 21702173

RE:RE:RE:Epuris= why styless is vindictive towards cipher and sold at $6...LOL

yes. iol

I'm a sore loser up a measily +350% on my investment.

your a loser Spike. Another funny rumur you started which is that i'm on leverage. ha. Where did that come from?

Have we reached the point where we need to post our holdings to shut you up? I'd love to show you how much own vs. how much you own. You sure make a big fuss over your 100 share position in the company.lol

Bullboard Posts

Rising miner increases graphite price, restarts Québec mill